Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer [Phase 3]
Phase 3 study comparing letrozole versus tamoxifen in postmenopausal women with hormone-sensitive resected primary breast cancer; the trial …
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Lapatinib and Trastuzumab With or Without Endocrine Therapy [Phase 2]
Phase 2 trial update evaluating lapatinib and trastuzumab with or without endocrine therapy in breast cancer; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer [NA]
Phase II neoadjuvant chemotherapy trial in locally advanced breast cancer evaluating doxorubicin followed by docetaxel-cisplatin.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women [NA]
Clinical trial assessing the effects of 4-Hydroxytamoxifen Gel on breast density, salivary sex steroids, and quality of life in premenopausa…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: High Risk Screening Breast MR Using a Rapid Imaging Exam
This clinical trial update notes that the study evaluating high-risk breast cancer screening with a rapid-imaging breast MRI has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast [Phase 1]
A Phase I trial evaluating the combination of RAD001 (everolimus) with capecitabine in metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for exemestane combined with sunitinib in metastatic breast cancer; trial phases 1 and 2 were terminated with results …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer [NA]
This completed clinical trial compared adding raloxifene to an exercise program versus exercise alone in women previously treated for breast…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer [Phase 2]
Phase II trial evaluating weekly or every-3-week ixabepilone in metastatic breast cancer has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer [Phase 2]
This update reports the completion of a Phase 2 neoadjuvant trial evaluating chemotherapy in combination with Celecoxib for invasive breast …
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy [Phase 2]
An update on a Phase 2 clinical trial assessing everolimus in breast cancer patients after pre-operative chemotherapy.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer [Phase 2]
Phase II study of Tariquidar (XR9576), a selective MDR-1 inhibitor, for chemotherapy-resistant advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects [Phase 1]
An exploratory Phase I open-label non-randomized study of [F18]CP-18 PET imaging in normal individuals and breast cancer patients was termin…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the combination of liposomal doxorubicin (Doxil) and bortezomib in patients with refractory hematol…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing lapatinib plus letrozole to letrozole alone in advanced/metastatic breast cancer completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Breast Cancer Screening Via Computer V. Phone [Phase 3]
A Phase 3 clinical trial comparing computer-based versus phone-based breast cancer screening has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Phase 2]
This Phase 2 trial evaluated dose-dense fluorouracil regimens (FU 75 and FU 90) as adjuvant therapy for early breast cancer and has complete…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Women With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement [Phase 1, Phase 2]
This entry documents a completed Phase 1/Phase 2 clinical trial evaluating capecitabine in combination with vinorelbine for older women with…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine [Phase 2]
This document reports the results of a Phase II trial of E7389 (eribulin) in patients with breast cancer previously treated with anthracycli…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial of capecitabine plus paclitaxel in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) [Phase 1]
A Phase 1 clinical trial update on HKI-272 (neratinib) assessing its effect on cardiac repolarization in breast cancer patients has complete…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study [Phase 2]
Phase 2 trial update on trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer (TRAIN study) has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases [Phase 2]
Phase 2 trial of imiquimod for breast cancer patients with chest wall recurrence or skin metastases has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer [Phase 2]
Phase II trial of Abraxane (nab-paclitaxel) given weekly as a single-agent therapy in first-line metastatic breast cancer has completed.